|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.22 USD | -2.00% |
|
-7.89% | -32.95% |
| 17/07 | EyePoint Pharmaceuticals Agrees to Settle US False Claims Act Allegations | MT |
| 16/07 | Stifel Initiates EyePoint Pharmaceuticals at Buy With $40 Price Target | MT |
| Market Cap | 104.55Cr 92Cr 85Cr 79Cr 147.34Cr 10TCr 149.98Cr 1.02TCr 398.43Cr 4.94TCr 392.5Cr 384.01Cr 17TCr | P/E 2026 * |
-3.5x | P/E 2027 * | -4.2x |
|---|---|---|---|---|---|
| Enterprise Value | 75Cr 66Cr 61Cr 56Cr 105.86Cr 7.27TCr 107.75Cr 733.91Cr 286.26Cr 3.55TCr 282Cr 275.9Cr 12TCr | EV / Sales 2026 * |
429x | EV / Sales 2027 * | 26.9x |
| Free-Float |
96.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: EyePoint, Inc.
| 1 day | -2.33% | ||
| 1 week | -7.89% | ||
| Current month | -14.34% | ||
| 1 month | -14.93% | ||
| 3 months | -11.04% | ||
| 6 months | -20.71% | ||
| Current year | -32.95% |
| 1 week | 12.06 |  | 13.79 |
| 1 month | 12.06 | | 15.92 |
| Current year | 11.3 | | 18.87 |
| 1 year | 9.4 | | 19.11 |
| 3 years | 3.91 | | 30.99 |
| 5 years | 2.19 | | 30.99 |
| 10 years | 2.19 | | 42.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jay Duker
CEO | Chief Executive Officer | 67 | 10/07/2023 |
George Elston
DFI | Director of Finance/CFO | 61 | 14/11/2019 |
Ramiro Ribeiro
CTO | Chief Tech/Sci/R&D Officer | 43 | 04/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Jay Duker
BRD | Director/Board Member | 67 | 10/07/2023 |
| Chairman | 77 | 10/09/2018 | |
John Landis
BRD | Director/Board Member | 73 | 25/10/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/07/26 | Fiscal year | Chief Executive Officer | 41,393 | 0.0494% | ||
| 30/06/26 | Fiscal year | Chief Technology Officer | 14,625 | 0.0174% | ||
| 25/05/26 | Fiscal year | Chief Financial Officer | 18,627 | 0.0222% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.00% | -7.89% | +16.78% | +16.89% | 104.55Cr | |
| +0.75% | +1.43% | +48.49% | +160.38% | 1,05700Cr | |
| +1.17% | +3.81% | +54.92% | +53.55% | 62TCr | |
| +0.49% | +1.72% | +35.65% | +80.80% | 45TCr | |
| +1.24% | +6.01% | +33.65% | +29.54% | 34TCr | |
| -1.03% | +1.22% | +35.27% | +39.34% | 30TCr | |
| +0.04% | +0.86% | +16.47% | +17.83% | 26TCr | |
| +0.09% | -2.09% | -27.75% | -41.27% | 22TCr | |
| +0.99% | +2.87% | +22.12% | +60.05% | 20TCr | |
| -0.83% | -2.90% | +15.18% | +67.89% | 16TCr | |
| Average | +0.08% | +0.26% | +25.08% | +48.50% | 36.15TCr | |
| Weighted average by Cap. | +0.57% | +1.57% | +35.67% | +77.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 17.52L 15.41L 14.31L 13.16L 24.68L 17Cr 25.13L 1.71Cr 66.75L 8.27Cr 65.76L 64.34L 29Cr | 3.28Cr 2.88Cr 2.68Cr 2.46Cr 4.62Cr 317.22Cr 4.7Cr 32Cr 12Cr 154.73Cr 12Cr 12Cr 536.8Cr |
| Net income | -32Cr -28Cr -26Cr -24Cr -45Cr -3.06TCr -45Cr -308.89Cr -120.48Cr -1.49TCr -118.69Cr -116.12Cr -5.18TCr | -29Cr -25Cr -24Cr -22Cr -41Cr -2.8TCr -41Cr -282.52Cr -110.2Cr -1.37TCr -108.56Cr -106.21Cr -4.74TCr |
| Net Debt | -29Cr -26Cr -24Cr -22Cr -41Cr -2.85TCr -42Cr -287.58Cr -112.17Cr -1.39TCr -110.5Cr -108.11Cr -4.82TCr | -16Cr -14Cr -13Cr -12Cr -23Cr -1.58TCr -23Cr -159.85Cr -62Cr -772.79Cr -61Cr -60Cr -2.68TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/26/24 | $12.25 | -1.76% | 2,40,547 |
| 23/26/23 | $12.47 | -1.50% | 12,84,723 |
| 22/26/22 | $12.66 | -2.99% | 10,63,990 |
| 21/26/21 | $13.05 | +3.08% | 15,85,308 |
| 20/26/20 | $12.66 | -4.81% | 10,99,731 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EYPT Stock
Select your edition
All financial news and data tailored to specific country editions
